Product Description
The COVID-19 panel is an in-vitro multiplex real-time reverse transcription polymerase chain reaction (rRT-PCR) assay for the identification of SARS-CoV-2 virus that is frequently found in the upper respiratory tract.
This method is highly accurate, extremely sensitive, and is used to identify the pathogen causing COVID-19 by amplifying and detecting genetic material (ribonucleic acid or RNA) of SARS-CoV-2.
The COVID-19 panel is capable of detecting
- SARS-CoV-2 N1 variants including Omicron sub-variants BA.4 and BA.5.
- Ribonuclease P (RP)
Usage Information
Reagent Storage and Use Guidelines | |
|
|
The Following is Included in the Kit | |
|
|
The Following is Supplied by the User: Materials |
|
|
|
Equipment | |
|
|
Instrumentation | |
CFX384 Touch Real-Time PCR Detection System (or equivalent) |
Download Product Information
Limitations of Use
This product has not been FDA cleared or approved, but has been authorized for emergency use by FDA under an EUA for use by authorized laboratories; This product has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. §
360bbb3(b)(1), unless the declaration is terminated or authorization is revoked sooner.